Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis

Alfonso Quintás-Cardama, Hagop M. Kantarjian, Taghi Manshouri, Deborah Thomas, Jorge Cortes, Farhad Ravandi, Guillermo Garcia-Manero, Alessandra Ferrajoli, Carlos Bueso-Ramos, Srdan Verstovsek

Research output: Contribution to journalArticlepeer-review

136 Scopus citations

Fingerprint

Dive into the research topics of 'Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences